Acupressure Application in Obesity Surgery 2345 (DB)

June 15, 2024 updated by: Duygu Balaban, Ataturk University

The Effect of Acupressure Applied After Bariatric Surgery on Gastrointestinal Functions, Pain and Anxiety

This research was conducted to determine the effect of acupressure applied to patients after bariatric surgery on gastrointestinal distress, pain and anxiety. The data of the study was collected at Aktif Private Kocaeli Hospital General Surgery Clinic between January 2022 and February 2023. The study was conducted with 90 (30 control, 30 intervention and 30 placebo) patients who underwent bariatric surgery. As a result of the research, application to ST25 and CV12 acupressure areas after bariatric surgery increased gas and stool output. It reduced abdominal distension. This enabled patients to start oral intake early. Application to the SP6 area reduced abdominal pain. Acupressure applied to the LI4 area was not effective in reducing nausea and vomiting. Massage to the HT7 acupressure area alone was not sufficient to relieve anxiety.

Study Overview

Detailed Description

This research was conducted to determine the intensity of acupressure treatment for gastrointestinal problems, pain and anxiety after bariatric surgery. The research was conducted using a placebo group, randomized controlled, detailed research model. The data of the study was collected at Aktif Private Kocaeli Hospital General Surgery Clinic between January 2022 and February 2023. The study was conducted with 90 (30 control, 30 intervention and 30 placebo) patients who underwent bariatric surgery. The data were brought together with the patient identification formula, postoperative gastrointestinal functions information formula, abdominal distension formula, visual analog scale, state-trait anxiety inventory scale, visual comparison operation, and patient happiness formula. The data were analyzed with the SPSS for Windows 22 package program. Records of numbers, percentages, minimum and maximum values, averages and standard deviations in the analysis of data. Mann Whitney U analysis, LSD, Dunnet C, Kruskall Wallis, Will coxon analyzes and t test records. The results were interpreted at the p< 0.05 significance level. Gastrointestinal capacity and recovery time, stool and gas output rates, difference in distension and abdominal pain score amounts, oral intake amounts and retching difference of the patients in acupressure, control and placebo distribution at the 6th, 12th, 24th and 48th months of the surgery were investigated. Children's movements and vomiting were evaluated with visual comparison performance. Anxiety was measured with the State-Trait Anxiety Inventory Scale at the ages of 6, 12, 24 and 48 after treatment. He recorded the Patient Satisfaction Form to obtain the patients' satisfaction after acupressure.

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Erzurum, Turkey
        • Atatürk Üniversitesi

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Patients undergoing Bariatric Surgery
  • Conscious patients between the ages of 18-65
  • Patients who can communicate
  • Patients without hearing-speech problems
  • Patients without any psychiatric disorder
  • Patients willing to cooperate
  • Patients who have never had acupressure before
  • Patients who do not have conditions such as hematoma, wound or fracture in the areas where acupressure will be applied

Exclusion Criteria:

  • Patients who withdraw from the study at any stage of the study
  • Patients admitted to the intensive care unit in the early postoperative period

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Acupressure Group
Acupressure application to CV12, ST25, SP6, LI4 and HT7 areas
Application was made to CV12, ST25, SP6, HT7 and LI4 acupressure areas.
No Intervention: Control Group
No action was taken.
Sham Comparator: Placebo Group
Massage application to feet, hands and abdomen areas that are not acupressure areas
Massage application to non-acupressure hand, foot and abdominal areas

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of pain after obesity surgery in the intervention, placebo and control groups with the Visual Analog pain scale
Time Frame: Pain was assessed at 24 hours postoperatively.
On the Visual Analog pain scale, a score of 0 means no pain and 10 means unbearable pain.
Pain was assessed at 24 hours postoperatively.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluating the distension of patients after obesity surgery with the Abdominal Distension Form
Time Frame: Distention of the patients was measured at the 24th postoperative hour.
The Abdominal Distension Form ranges from 0 to no distension and 10 to severe distension.
Distention of the patients was measured at the 24th postoperative hour.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measuring the gastrointestinal functions of patients after obesity surgery with the Gastrointestinal Functions Information Form
Time Frame: Gastrointestinal functions of the patients were measured at 6, 12, 24 and 48 hours after surgery.
The Gastrointestinal Functions Information Form includes a total of 6 questions about the patients' stool output, gas output, oral intake amount, nausea, vomiting and retching. Patients have two ways of answering: yes or no.
Gastrointestinal functions of the patients were measured at 6, 12, 24 and 48 hours after surgery.
Measuring nausea and vomiting in patients after obesity surgery with the Visual Comparison Scale.
Time Frame: Measurements were taken at 6, 12, 24 and 48 hours after surgery.
In the Visual Comparison Scale, the lowest value of the patients' nausea and vomiting was used as 0 mm, and the highest value was 100 mm.
Measurements were taken at 6, 12, 24 and 48 hours after surgery.
Measuring the anxiety of patients after bariatric surgery with the State-Trait Anxiety Inventory.
Time Frame: The patients' anxiety was measured at the 24th hour after surgery.
There are two forms in the State-Trait Anxiety Inventory questionnaire. The first form consists of 20 questions measuring the state anxiety of the patients, and the second form contains 20 questions measuring the trait anxiety of the patients. The lowest score in these questions is 1 and the highest score is 4.
The patients' anxiety was measured at the 24th hour after surgery.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2022

Primary Completion (Actual)

February 20, 2023

Study Completion (Actual)

March 15, 2023

Study Registration Dates

First Submitted

May 22, 2024

First Submitted That Met QC Criteria

June 15, 2024

First Posted (Actual)

June 21, 2024

Study Record Updates

Last Update Posted (Actual)

June 21, 2024

Last Update Submitted That Met QC Criteria

June 15, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • DBalaban

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bariatric Surgery

Clinical Trials on acupressure

Subscribe